-
Results of the 2013 Contraceptive Technology Update Contraception Survey indicate that use of the NuvaRing contraceptive vaginal ring and the Evra contraceptive patch is consistent with 2012's figures.
-
Responses to the 2013 Contraceptive Technology Update Contraception Survey indicate that many clinicians have moved to remove one hurdle to contraception by adopting the Quick Start method of method initiation.
-
Women continue to choose long-acting reversible contraceptive (LARC) methods, say respondents to the 2013 Contraceptive Technology Update Contraception Survey.
-
Intimate partner violence (IPV) and reproductive and sexual coercion disproportionately affect women. Such behavior is aimed at establishing control of one partner over the other.
-
According to results from the 2013 Contraceptive Technology Update Contraception Survey, while many women continue to pick combined oral contraceptives (OCs), other options are making inroads on the popular choice.
-
Clinics looking to increase use of long-acting reversible contraceptive (LARC) methods have tools and evidence to support their actions.
-
Just-published papers in the Journal of the American Medical Association add to heightened concern regarding hormone therapy (HT).
-
Findings from a new Australian study indicate that use of modern, low-dose oral contraceptives (OCs) containing 50 mcg estrogen or less do not appear to appreciably raise the risk of ischemic stroke in healthy women.
-
The word is getting out about emergency contraception (EC). A just-released national survey reports that two-thirds of women ages 18-44 are aware that there is something a woman can do to prevent pregnancy in the few days following sexual intercourse.
-
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY.